Dr. Noa Biran, MD

Dr. Biran practices at Hackensack University Medical Center in Hackensack, New Jersey, part of Hackensack Meridian Health.

Dr. Biran's NPI, 1023277910, was assigned on June 5, 2008. Dr. Biran graduated from George Washington University School of Medicine and Health Sciences in 2008. Dr. Biran holds New Jersey license 25MA09466300.

Dr. Biran's primary practice is Hackensack University Medical Center, at 30 Prospect Ave, Hackensack, NJ 07601 in Bergen County. The practice phone is (551) 996-2000.

Dr. Biran's primary practice is Hackensack University Medical Center in Hackensack, New Jersey, part of Hackensack Meridian Health. Dr. Biran is also affiliated with Morristown Medical Center. The medical group on file is Regional Cancer Care Associates. Dmand AI also links Dr. Biran to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Biran practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Biran's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Biran is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Biran's licenses on file in 3 states: New Jersey, New York and Pennsylvania.

Dmand AI lists anemia, chronic anemia, chronic leukemia, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Biran treats.

CMS data shows 3,713 Medicare services from Dr. Biran across 14 procedure codes in 2024, for 466 Medicare patients. Medicare paid $233,210 for them.

CMS counts 466 Medicare patients who saw Dr. Biran in 2024. The largest group is 65 to 74, with 213 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 3.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Biran's median patient age at 71, with 47% women.

In 2024, Dr. Biran wrote 1,146 Medicare Part D claims for 302 patients. 78% of them were for generic drugs. CMS names the drug for 831 of them, across 27 drugs with 11 or more claims each, at $3,246,264 in total drug cost. In 2023, CMS named 929 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Biran for performance year 2024, reported individually. Dr. Biran accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Biran as offering telehealth.

Dmand AI links 70 papers to Dr. Biran, published from 2014 to 2025. 2020 was the busiest year, with 13. The most frequent topics are Multiple Myeloma, Antineoplastic Combined Chemotherapy Protocols and Hematopoietic Stem Cell Transplantation. Dr. Biran has published most often in Clin Lymphoma Myeloma Leuk. Dr. Biran's most frequent co-authors are Ajai Chari, MD, Sundar Jagannath, MD and Harsh V. Parmar, MD.

Dmand AI links Dr. Biran to 18 clinical trials, 10 of them phase 1/2 studies. 5 are still active or recruiting. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Myelodysplastic Syndromes. Hackensack Meridian Health sponsors the most, 8.

CMS Open Payments shows 598 general payments to Dr. Biran from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Amgen Inc. paid the most, $139,040. It also lists 4 research payments totaling $291 in 2018.

Dr. Biran graduated from George Washington University School of Medicine and Health Sciences in 2008.

Dr. Biran is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.